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Abstract
Background: Young injection drug users (IDUs) may be at increased risk of premature mortality
due to the health risks associated with injection drug use including overdoses and infections.
However, there has been little research conducted on mortality causes, rates and associations
among this population. We undertook this study to investigate patterns of premature mortality,
prior to age 30 years, among young IDUs.
Methods: Since 1996, 572 young (≤29 years) IDUs have been enrolled in the Vancouver Injection
Drug Users Study (VIDUS). Semi-annually, participants have completed an interviewer-
administered questionnaire and have undergone serologic testing for HIV and hepatitis C (HCV).
Mortality data have been continually updated through linkages with the Provincial Coroner's Office.
Crude and age-specific mortality rates, standardized mortality ratios, and life expectancy measures
were calculated using person-time methods. Predictors of mortality were identified using Cox
regression analyses.
Findings: Twenty-two participants died prior to age 30 years during the follow-up period for an
overall crude mortality rate of 1,368 per 100,000 person-years. Overall, young IDUs were 16.4
times (95% confidence interval [CI]; 9.1–27.1) more likely to die; young women IDUs were 54.1
times (95%CI; 29.6–90.8) and young men IDUs were 12.9 times (95%CI; 5.5, 25.3) more likely to
die when compared to the Canadian non-IDU population of the same age. The leading observed
cause of death among females was: homicide (N = 9); and among males: suicide (N = 3) and
overdose (N = 3). In Cox regression analyses, factors associated with mortality were, HIV infection
(Hazard Ratio [HR]: 4.55; CI: 1.92–10.80) and sex work (HR: 2.76; CI: 1.16–6.56).
Interpretation: Premature mortality was 13 and 54 times higher among young men and women
who use injection drugs in Vancouver than among the general population in Canada. The majority
of deaths among the women were attributable to homicide, suggesting that interventions should
occur not only through harm reduction services but also through structural interventions at the
legal and policy level.
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Background
Premature mortality among injection drug users (IDUs) is
higher than in the general population with rates of mor-
tality estimated to range between 0.8–3.26/100 person-
years [1,2]. Young IDUs are at higher risk for a number of
adverse health outcomes, including blood-borne infec-
tion, than among young people in the general popula-
tion[3]. In a study of new onset injection drug users,
mortality rates varied by calendar year, were elevated in
comparison to the general population and were estimated
to be 3.3 per 100-preson years [2]. In 2002, Roy et al.
reported that street youth in Montreal, Quebec, aged 29
years and younger, had a standardized mortality ratio of
11.4 and one of the independent predictors of mortality
was injection drug use [4]. Younger IDUs represent an
important group to examine with respect to mortality due
to their higher risk for drug related harms [5,6] and the
opportunity to offer new information regarding avenues
for prevention among this vulnerable population.
Recent studies in the United States and Scotland have
found that mortality rates peaked among IDUs in the
mid-1990s due to an increase in HIV/AIDS related deaths
and have since declined [2,7]. Mortality among IDUs typ-
ically result from infectious diseases, overdose and inju-
ries [8-10]. Overdose is a leading cause of death among
IDUs [11] and varies between calendar years depending
on factors such as purity and quality of drug availability
and potentially on the HIV status among individuals
[12,13]. Among IDUs in Edinburgh, Scotland deaths due
to overdose and suicide were higher among younger IDUs
than among older IDUs, with higher proportions of
young males than females dying by suicide [7]. In the
study of street youth in Montreal, Quebec, overdose
deaths and suicide represented the leading causes of pre-
mature mortality [4].
Investigating causes of mortality among IDUs is impor-
tant not only as a means for understanding risk among
this population, but mortality can also be a measure of
how well existing public health interventions are working
to address drug-related harms. Studies have shown
increased mortality rates since the advent of AIDS among
IDUs, particularly prior to the advent of HIV antiretroviral
therapy [7,14]. Nevertheless, other studies have shown
that IDUs are more likely to die without ever accessing
lifesaving HIV treatment when compared to other popula-
tions affected by HIV [15]. This information provides
public health agencies with knowledge regarding a gap in
the scope and effectiveness of existing systems of care.
Thus, information on mortality can provide critical public
health information for authorities to gauge how well
existing services have been effective in addressing the
ongoing public health crisis among IDUs.
This study was designed to investigate factors associated
with mortality prior to age 30 years among IDUs and to
determine rates and causes of premature mortality in this
population.
Methods
Study population
The Vancouver Injection Drug User Study (VIDUS) is a
prospective study of IDUs who have been recruited
through self-referral and street outreach from Vancouver's
Downtown Eastside (DTES) since May 1996. To date there
have been over 1600 IDUs enrolled, among whom over
500 are young (aged ≤29 years). The Downtown Eastside
is Vancouver's poorest neighborhood where an estimated
4,700 IDUs and 1,000 street youth reside in an area of
approximately ten city blocks, and where inexpensive
housing in the form of hotels and single room occupan-
cies (SROs) are abundant. The cohort has been described
in detail previously [16]. Briefly, persons were eligible for
this study if they had injected illicit drugs at least once in
the previous month confirmed by track site inspection,
were aged 14 years and older and resided in the greater
Vancouver region. At baseline and semi-annually, subjects
provided venous blood samples and completed an inter-
viewer-administered questionnaire. All participants pro-
vided informed consent, and were given a stipend ($20
CDN) at each study visit. The study has been approved by
the University of British Columbia's Research Ethics
Board.
Sources of information on cause of death
The VIDUS office is situated in the hub of the DTES and
the office serves as a drop-in where participants regularly
stop by for coffee and conversation. Many of the VIDUS
staff have been working in the community for several
years and stay connected with residents and other com-
munity workers. This close community serves as an infor-
mal watch where information is shared when residents
become missing, ill, incarcerated or die. This informal sys-
tem is complemented by regular linkages with the provin-
cial Coroner's Office where the coroner's report is
reviewed for each confirmed death within the study. In
addition, the provincial Vital Statistics Agency is reviewed
to confirm deaths among participants twice annually.
Thus, information on cause of death were obtained
through regular follow-up, coroner's reports, and annual
electronic linkages with BC Vital Statistics. These methods
help to ensure the accuracy of information and avoid
potential under representation due to reporting delays.
The underlying cause of death reported on each death
record was coded in accordance with the International
Classification of Diseases, Tenth Revision (ICD-10).Harm Reduction Journal 2007, 4:1 http://www.harmreductionjournal.com/content/4/1/1
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Statistical analyses
Socio-demographic variables included in these analyses
were gender, ethnicity (Aboriginal vs. other) [17], HIV
and HCV-positivity and homelessness. Aboriginal is self-
reported and includes: First Nations people, Inuit and/or
Métis people. Homelessness was defined as sleeping in
the street, shelter and/or squat. Drug and sexual risk vari-
ables included in these analyses were history of sexual
abuse, sex work, greater than once daily crack cocaine use
and greater than once daily injection of heroin, cocaine
and/or speedball (a mixture of heroin and cocaine), and
use of methadone maintenance therapy (MMT). Sex-work
involvement was defined as exchanging sex for money,
goods, drugs, or shelter. All time-updated variables refer
to activities in the six months prior to each semi-annual
follow-up visit with the exception of sexual abuse, defined
as ever occurring.
Baseline characteristics are described in Table 1 and causes
of death are described in Table 2. For the longitudinal
analyses, Table 3, the follow-up period for each partici-
pant started at baseline and ended at the first of the fol-
lowing events: death or age 30 years. Mortality rates were
calculated overall and by subgroups defined by variables
selected from the above listed characteristics, based on the
literature and appropriateness for the sample size. Mortal-
ity rates were calculated using the person-time method
(18); 95% confidence intervals (CI) were calculated using
the Poisson distribution.
Standardized mortality ratios were calculated using the
indirect method of standardization by sex and age group.
The comparison group was the Canadian population of
the same age in 2000. Abridged life tables were calculated
using methods adopted by Lopez et al. at the World
Health Organization [19]. Predictors of mortality were
identified using univariable and multivariable Cox regres-
sion analyses. All variables with p values ≤ 0.05 in univar-
iable analyses were included in multivariable analyses.
Results
Characteristics of the study participants
Between May 1996 and December 2004, 572 participants
aged ≤ 29 years were enrolled into the study. Participants
completed between 1 and 15 questionnaires (average 7
per participant; 83% completed at least 1 follow-up ques-
tionnaire following the baseline interview). During fol-
low-up 182 participants reached 30 years of age. In total,
participants accumulated 1608 person-years of follow-up
time prior to age 30 years.
The median age of participants at study entry was 23.9
(IQR: 20.9–26.3) and the number of years injecting was 4
(IQR: 1.5–8). As indicated in Table 1, 47% were female
and 29% were of Aboriginal ancestry. The percentage of
young people HIV and HCV infected was 16% and 57%
respectively and 25% were homeless. Of the sex risk vari-
ables, 40% reported a history of sexual abuse and 44%
engaged in sex work. Among the young participants, 10%
had smoked crack daily, 45% had injected heroin daily,
33% had injected cocaine daily, 14% had injected speed-
balls (heroin and cocaine combined) daily and 5% had
accessed methadone maintenance therapy (MMT).
Mortality
In total, 42 deaths occurred during the study period, 20 of
those occurring after 30 years of age and were excluded
from further analyses. Thus, there were 22 deaths that
occurred during the follow-up period among participants
aged 29 years and younger. Of note, 1 of the observed
deaths was classified as "assault" and for this study we
included it in the homicide category. Thus, among
females, the leading cause of death (refer to Table 2) was
homicide (n = 9) and among males, suicide (n = 3) and
overdose death (n = 3). Death due directly to HIV infec-
tion occurred among 2 female participants and 1 male
participant.
The 22 deaths observed among this population during
follow-up represented a mortality rate of 1368 per
100,000 person-years. Among females, the mortality rate
was 1645 per 100,000 person-years and among males, the
rate was 1045 per 100,000 person years. In comparison
with the Canadian population of the same age in 2000,
young IDUs were 16.4 times (95% confidence interval
[CI]; 9.1–27.1) more likely to die; women were 54.1 times
(95%CI; 29.6–90.8) and men were 12.9 times (95%CI;
5.5, 25.3) more likely to die. At age 15, IDUs could expect
to live another 36.8 years, compared to the Canadian pop-
ulation at age 15 who could expect to live another 64.8
years or nearly double the life expectancy of IDUs in this
study population.
Univariable and multivariable Cox regression analyses
assessing associations between mortality and participant
characteristics are presented in Table 3. In univariable
analyses, factors associated with mortality among the
study population were sex work (Hazard Ratio [HR]; 2.76
[95%CI; 1.16–6.56]) and HIV infection (HR; 4.55
[95%CI; 1.92–10.80]). The only factor to remain signifi-
cantly associated with mortality among participants in
multivariable analyses was HIV infection (HR; 4.55
[95%CI; 1.92–10.80]).
Discussion
The mortality rate observed among this population of
young people is high. Young male and female IDUs in this
setting had rates of mortality that were 12 and 51 times
higher respectively than the Canadian population of the
same age. Life expectancy at age 15 years is half of what isHarm Reduction Journal 2007, 4:1 http://www.harmreductionjournal.com/content/4/1/1
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observed at a national level. Particularly concerning was
the number of deaths due to homicide among the women
in the study.
A previous study identified mortality from homicide as
the leading cause of death among young homeless males
and females in an urban setting in the United States where
homicide rates are generally higher than in other devel-
oped nations[20]. However in this Canadian setting
where homicide deaths rank low, young drug dependent
women appear to be at very high risk of death by this
means. The high number of women dying by homicide
combined with the generally low rate of homicide in this
setting warrants public health intervention, particularly
due to the preventable nature of this cause of death. In this
study, approximately half of the participants were
involved in sex work at baseline and among females, this
figure approaches 80% (data not shown). In longitudinal
analysis, sex work was an important predictor of mortality
in this study, however this factor did not reach signifi-
cance in multivariable analyses likely due to power issues.
The relationship between injection drug dependency,
younger age, female sex and sex work has previously been
shown [21-24].
Of note, investigation of Robert Pickton for the serial mur-
ders of drug dependent women from Vancouver's Down-
town Eastside has recently begun [25]. This investigation
may account for the high number of homicide deaths
observed among women in this setting. Other similar
investigations in parts of Mexico and the US (Ciudad Jua-
rez and the Green River serial killer investigations) suggest
that women, and particularly young women, who engage
in sex work are at high risk for being targeted by sexual
predators [26,27]. It has also been suggested by commu-
nity workers that young women who deal drugs to sup-
port their habits may rank low in the hierarchy of drug
dealing relationships and may be at risk for death by
"being made an example of" when using the drugs they
are meant to sell. The development of public health inter-
ventions to reduce the risk for violence among young
injection drug dependent women who engage in sex work
is important. More recently, legal reform for sex workers
in this setting has been proposed and these findings
underscore the need to support legal reform and other
harm reduction initiatives for sex workers to reduce the
risk of violence and homicide death[28]. Additional pub-
lic health interventions require further investigation, par-
ticularly qualitative, to ascertain types of interventions
that may be acceptable to young female IDUs who also
Table 1: Characteristics of the 572 young (≤29 years) Vancouver injection drug user study participants at baseline.
Characteristic No. (%)
Females 268 (47%)
Aboriginal 163 (29%)
HIV Positive at Baseline 92 (16%)
HCV Positive at Baseline 326 (57%)
Homeless in the 6 mos. prior 144 (25%)
Sex Abuse Ever 231 (40%)
Sex Work in the 6 mos. prior 252 (44%)
≥1 per day Crack in the 6 mos. prior 57 (10%)
≥1 per day Heroin in the 6 mos. prior 260 (45%)
≥1 per day Cocaine in the 6 mos. prior 188 (33%)
≥1 per day Speedballs in the 6 mos. prior 78 (14%)
Methadone Maintenance Therapy in the 6 mos. prior 31 (5%)
Table 2: Profile of cause of death among young (≤29 years) injection drug users in Vancouver who died between 1996 and 2006 (N = 
22).
Cause of Death Females No. Males No. Total
Homicide 9 9
Accident 1 1 2
Suicide 3 3
H I V 213
O v e r d o s e 134
Undetermined Illness 1 1
Total No. 14 8 22Harm Reduction Journal 2007, 4:1 http://www.harmreductionjournal.com/content/4/1/1
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engage in sex work. Given the potentially deadly conse-
quences, considering innovative drug treatment and phar-
maco-therapeutic interventions, such as prescription drug
maintenance, may help to reduce drug-related harms,
including premature mortality, in this population [29].
In the final Cox model, the only predictor of premature
mortality was HIV infection. Similarly, Roy et al. found
that HIV was the strongest predictor of mortality among
Montreal street youth; however HIV represented a small
proportion of the overall causes of death [4]. The consist-
ency between these results may imply that youth who are
vulnerable to premature mortality are also those more
vulnerable to blood-borne infections.
Similar to other findings regarding mortality among
younger age groups and males in particular, death by sui-
cide and overdose were common[30]. In this study, the
deaths by overdose were not deemed intentional by coro-
ner reports, however other literature has indicated that
overdose may be one of the ways that young people com-
mit suicide and among IDUs, intentional suicide by over-
dose may be may be hard to prove[30]. Suicide among
young people is always a tragic phenomenon and given
the higher risk for suicide, community suicide prevention
resources should be mobilized within this popula-
tion[31]. In addition, ensuring overdose prevention edu-
cation and available tools are accessible to younger IDUs
may be important for prevention of premature mortality
in this population.
There are several limitations that should be considered
with regards to the data presented here. First, this study
sample was relatively small and although a smaller
number of associations were considered, power issues
may have constrained the longitudinal analyses. The sec-
ond limitation may be the potential for misclassification
bias relating to self-reported behaviours, however the
Table 3: Mortality rates and cox regression analyses of mortality among young (≤29 years) injection drug users (N = 572) in Vancouver 
between 1996 and 2006.
Characteristic No. of Deaths Mortality Rate per 100,000 
Person Years
Unadjusted Hazard Ratio 
(95% CI)
Adjusted Hazard Ratio (95% CI)
Older than 24 yrs.
Yes
No
13
9
1,679
1,213
1.41 [0.60–3.30]
Female
Yes
No
14
8
1,645
1,057
1.77 [0.74–4.22]
Aboriginal
Yes
No
7
15
1,282
1,412
1.07 [0.44–2.62]
HIV
Yes
No
13
9
3,137
1,035
4.55 [1.92–10.80] 4.01 [1.67–9.56]
HCV
Yes
No
15
7
1,689
959
0.96 [0.37–2.51]
Homelessness
Yes
No
5
17
1,220
1,412
1.19 [0.44–3.25]
Sex Work
Yes
No
16
6
2,159
692
2.76 [1.16–6.56] 1.97 [0.80–4.84]
Sexual Abuse
Yes
No
12
10
1,829
1,050
1.66 [0.72–3.84]
≥1 per day Heroin
Yes
No
10
12
1,389
1,351
0.84 [0.35–1.97]
≥1 per day Cocaine
Yes
No
8
14
1,501
1,302
1.40 [0.58–3.37]
≥1 per day Crack
Yes
No
5
17
2,959
1,181
2.41 [1.00–5.81] 1.94 [0.79–4.80]Harm Reduction Journal 2007, 4:1 http://www.harmreductionjournal.com/content/4/1/1
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interviewers are trained to probe for any misleading infor-
mation and every precaution is taken to assure the partic-
ipant of confidentiality. Third, there is a possibility that
the number of deaths occurring were underestimated, par-
ticularly if the participant was lost to follow-up or the
death occurred out-of-province. Finally, in this setting, a
higher number of homicides were found among young
women than in other studies suggesting that these results
may represent an anomaly. However, the experiences of
sex workers who work without legal protection, such as in
most North American settings and other settings world-
wide, violence and the risk of predation is high and for
drug dependent women, the risks may be even
greater[32]. There is a need for more research on violence
and predation among young women involved in sex work
and a need for better protection of their human rights.
Mortality among IDUs may be an assumed risk conse-
quential to a high-risk behaviour. However the data pre-
sented here suggests that the majority of risk for
premature mortality among young IDUs is resulting, not
directly from injection drug use, but indirectly from pre-
ventable causes. Clearly, better public health interven-
tions must be implemented targeting this population
including emergency and long term housing options,
alternative employment training for young sex workers
and accessible substitution therapies for young IDUs. In
addition, given the ongoing harms associated with sex
work, structural changes including legal and policy reform
are warranted. The high rates of mortality presented here
should send a clear message to public health agencies that
young IDUs have unique risk profiles and innovative
interventions are required to avert preventable premature
mortality among this population.
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